Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.52 USD | +1.57% | -1.09% | -31.72% |
04-15 | TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR | CI |
03-22 | Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating | MT |
Business Summary
Number of employees: 227
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Soft-tissue Reconstruction Solutions
100.0
%
| 41 | 100.0 % | 58 | 100.0 % | +41.13% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 41 | 100.0 % | 58 | 100.0 % | +41.13% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Antony Koblish
FOU | Founder | 58 | 16/04/12 |
Roberto Cuca
DFI | Director of Finance/CFO | 57 | 26/09/21 |
Marissa Conrad
CTO | Chief Tech/Sci/R&D Officer | - | 23/05/21 |
Paul Talmo
CTO | Chief Tech/Sci/R&D Officer | 57 | 31/01/14 |
Investor Relations Contact | - | - | |
D. Taylor Ocasio
LAW | General Counsel | - | 17/04/22 |
Megan Smeykal
AUD | Comptroller/Controller/Auditor | 48 | 30/11/19 |
Bruce Freedman
PRN | Corporate Officer/Principal | - | 31/12/20 |
Peter Murphy
PRN | Corporate Officer/Principal | 52 | 28/01/20 |
Michael Leonard
PRN | Corporate Officer/Principal | - | 31/03/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Colleran
BRD | Director/Board Member | 66 | 19/04/20 |
Douglas Evans
CHM | Chairman | 59 | 19/04/20 |
Antony Koblish
FOU | Founder | 58 | 16/04/12 |
Vince Burgess
BRD | Director/Board Member | 59 | 31/05/14 |
Federica O’Brien
BRD | Director/Board Member | 66 | 12/11/19 |
Kurt Azarbarzin
BRD | Director/Board Member | 61 | 05/11/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,653,939 | 22,995,548 ( 93.27 %) | 0 | 93.27 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.72% | 110M | |
-2.54% | 187B | |
-1.85% | 106B | |
-4.26% | 66.9B | |
+1.39% | 49.45B | |
+16.82% | 48B | |
+5.67% | 40.84B | |
+3.49% | 26.48B | |
+0.65% | 26.25B | |
+17.01% | 24.62B |
- Stock Market
- Equities
- TELA Stock
- Company TELA Bio, Inc.